» Articles » PMID: 29058957

CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/+) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD)

Overview
Publisher Sage Publications
Specialty Biochemistry
Date 2017 Oct 24
PMID 29058957
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Connective tissue growth factor (CTGF, also named CCN2) plays an important role in the development of tubulointerstitial fibrosis, which most critically determines the progression to end-stage renal failure in autosomal-dominant polycystic kidney disease (ADPKD), the most common genetically caused renal disease. We determined CTGF expression in a well-characterized animal model of human ADPKD, the PKD/Mhm (cy/+) rat. Kidneys of 12 weeks old (cy/+) as well as (+/+) non-affected rats were analyzed for CTGF RNA and protein expression by RT-PCR, Northern and Western blot analyses, in situ hybridization, and IHC. Besides the established expression of CTGF in glomerular cells in kidneys of wild-type (+/+) animals, in (cy/+) rats, CTGF mRNA and protein were robustly expressed in interstitial, stellate-shaped cells, located in a scattered pattern underlying the cystic epithelium and in focal areas of advanced tubulointerstitial remodeling. Renal CTGF mRNA and protein expression levels were significantly higher in (cy/+) rats compared with their (+/+) littermates. Detection of CTGF expression in cells adjacent to cystic epithelium and in areas of marked fibrosis suggests a role in the local response to cyst development and indicates that CTGF may be a relevant factor contributing to tubulointerstitial fibrosis in polycystic kidney disease.

Citing Articles

Myocardin-Related Transcription Factor Mediates Epithelial Fibrogenesis in Polycystic Kidney Disease.

Lichner Z, Ding M, Khare T, Dan Q, Benitez R, Praszner M Cells. 2024; 13(11.

PMID: 38891116 PMC: 11172104. DOI: 10.3390/cells13110984.


Connective Tissue Growth Factor Is Related to All-cause Mortality in Hemodialysis Patients and Is Lowered by On-line Hemodiafiltration: Results from the Convective Transport Study.

den Hoedt C, van Gelder M, Grooteman M, Nube M, Blankestijn P, Goldschmeding R Toxins (Basel). 2019; 11(5).

PMID: 31086050 PMC: 6563290. DOI: 10.3390/toxins11050268.

References
1.
Obermuller N, Gretz N, Kriz W, van der Woude F, Reilly R, Murer H . Differentiation and cell polarity during renal cyst formation in the Han:SPRD (cy/+) rat, a model for ADPKD. Am J Physiol. 1997; 273(3 Pt 2):F357-71. DOI: 10.1152/ajprenal.1997.273.3.F357. View

2.
Schrier R . Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2009; 20(9):1888-93. DOI: 10.1681/ASN.2008080882. View

3.
Gauer S, Segitz V, Goppelt-Struebe M . Aldosterone induces CTGF in mesangial cells by activation of the glucocorticoid receptor. Nephrol Dial Transplant. 2007; 22(11):3154-9. DOI: 10.1093/ndt/gfm410. View

4.
Neudecker S, Walz R, Menon K, Maier E, Bihoreau M, Obermuller N . Transgenic overexpression of Anks6(p.R823W) causes polycystic kidney disease in rats. Am J Pathol. 2010; 177(6):3000-9. PMC: 2993307. DOI: 10.2353/ajpath.2010.100569. View

5.
Rossetti S, Consugar M, Chapman A, Torres V, Guay-Woodford L, Grantham J . Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2007; 18(7):2143-60. DOI: 10.1681/ASN.2006121387. View